Bank of New York Mellon’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Buy |
65,152
+14,508
| +29% | +$58.3K | ﹤0.01% | 3846 |
|
|
2025
Q1 | $176K | Sell |
50,644
-16
| -0% | -$56 | ﹤0.01% | 3897 |
|
|
2024
Q4 | $333K | Buy |
50,660
+2,677
| +6% | +$17.6K | ﹤0.01% | 3703 |
|
|
2024
Q3 | $434K | Buy |
47,983
+16,177
| +51% | +$146K | ﹤0.01% | 3585 |
|
|
2024
Q2 | $510K | Buy |
31,806
+3,483
| +12% | +$55.9K | ﹤0.01% | 3570 |
|
|
2024
Q1 | $444K | Buy |
28,323
+14,213
| +101% | +$223K | ﹤0.01% | 3596 |
|
|
2023
Q4 | $189K | Buy |
+14,110
| New | +$189K | ﹤0.01% | 3964 |
|